Formulations for treating acid reflux comprising sodium alginate
AssigneePharagen LLC
InventorJoseph Ryan Smolarz
Life of this patent
Estimating the term…
Abstract
The disclosure provides for pharmaceutical compositions comprising an alginate salt, such as sodium alginate. The disclosure further provides for processes and methods for making pharmaceutical compositions. In yet a further aspect, the disclosure provides for methods of utilizing a pharmaceutical composition for treatment of acid reflux diseases. In another aspect, the disclosure provides for formulations suitable for oral use in dosage forms of capsules and dry powders.
Claims17
A method of treating acid reflux disease selected from the group consisting of laryngopharyngeal reflux and erosive esophagitis, comprising administering to an individual in need thereof a pharmaceutical composition comprising:
- (i) one or more alginate salts, present in an amount from about 100 mg to 2,000 mg,
- (ii) sodium bicarbonate, present in an amount from about 1 mg to 100 mg,
- (iii) a calcium composition, present in an amount from about 40 mg to 60 mg,
- (iv) optionally one or more natural or artificial sweetener or flavorants, present in an amount from about 1.0 mg to 10,000 mg, and
- wherein the pharmaceutical composition is formulated as a powder or capsule form prior to dissolution, and when dissolved in a liquid the composition forms an alginate raft prior to administration to an individual.
Dependencies are inferred from the claim text.